Scott Vandermeer
Founder at Infusion 51A LP
Scott Vandermeer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Infusion 51A LP | Founder | 2015-03-31 | - |
| Corporate Officer/Principal | 2015-03-31 | - | |
| International Infusion LP | Director of Finance/CFO | 2011-03-31 | - |
Vivacitas Oncology, Inc.
 Vivacitas Oncology, Inc. Medical/Nursing ServicesHealth Services Vivacitas Oncology, Inc. is a private clinical stage biopharmaceutical company founded in 2015 by Dr. Joseph Rubinfeld and Infusion 51a, LP. The company is based in Walnut Creek, CA. Vivacitas Oncology is focused on combating cancers that have proven to be resistant to current treatment modalities. The company aims to improve upon well-known chemotherapies with demonstrated effect, but which also possess challenges with potency, toxicity, stability, and other issues limiting their use. The CEO is Mark J. Suseck. | Director/Board Member | - | - |
| Director of Finance/CFO | - | - | |
| Founder | 2014-12-31 | - |
Career history of Scott Vandermeer
Former positions of Scott Vandermeer
| Companies | Position | Start | End |
|---|---|---|---|
| AVANT DIAGNOSTICS INC | Chief Executive Officer | 2017-12-10 | - |
| Director of Finance/CFO | 2017-12-10 | 2019-12-31 |
Training of Scott Vandermeer
| University of Illinois | Undergraduate Degree |
Statistics
International
| United States | 5 |
| 2 |
Operational
| Director of Finance/CFO | 3 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Theralink Technologies, Inc. (Colorado)
 Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Theralink Technologies, Inc. engages in the provision of biomarker assay services in the areas of oncology. The firm offers personalized medicine data through TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying drug treatments. It develops phosphoproteomic technologies that measure the activation status of signaling pathways. The company was founded on October 16, 2008 and is headquartered in Golden, CO. | Health Technology |
| Infusion 51A LP | Miscellaneous |
| International Infusion LP | |
Vivacitas Oncology, Inc.
Vivacitas Oncology, Inc. Medical/Nursing ServicesHealth Services Vivacitas Oncology, Inc. is a private clinical stage biopharmaceutical company founded in 2015 by Dr. Joseph Rubinfeld and Infusion 51a, LP. The company is based in Walnut Creek, CA. Vivacitas Oncology is focused on combating cancers that have proven to be resistant to current treatment modalities. The company aims to improve upon well-known chemotherapies with demonstrated effect, but which also possess challenges with potency, toxicity, stability, and other issues limiting their use. The CEO is Mark J. Suseck. | Health Services |
- Stock Market
- Insiders
- Scott Vandermeer
- Experience
